FDA Approves Sodium Oxybate (Xyrem) for Pediatric Narcolepsy

Share this post

The FDA has approved expanded labeling for sodium oxybate (Xyrem) to include treatment of cataplexy or excessive daytime sleepiness in pediatric narcolepsy.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply